| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6127425 | MAYNE PHARMA COMMRCL | Oral liquid medicine solution |
Jun, 2018
(5 years ago) | |
Soltamox is owned by Mayne Pharma Commrcl.
Soltamox contains Tamoxifen Citrate.
Soltamox has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Soltamox are:
- US6127425
Soltamox was authorised for market use on 29 October, 2005.
Soltamox is available in solution;oral dosage forms.
The generics of Soltamox are possible to be released after 26 June, 2018.
Drugs and Companies using TAMOXIFEN CITRATE ingredient
Market Authorisation Date: 29 October, 2005
Treatment: NA
Dosage: SOLUTION;ORAL
More Information on Dosage
SOLTAMOX family patents
